TKIs Do Not Add Protective Benefit Against Peripheral Neuropathy in Patients With ALL Receiving VincristineDecember 16th 2022
Patients with acute lymphoblastic leukemia who received vincristine-based regimens with TKIs did not experience more chemotherapy-induced peripheral neuropathy vs those who did not.
McNally Spotlights Need for Better CIPN Research in Aggressive LymphomasJuly 25th 2022
Gretchen McNally, PhD, ANP-BC, AOCNP, discusses the rationale behind a pilot study which will assess patient reported outcomes for patients with lymphoma who develop chemotherapy-induced peripheral lymphoma.
Gretchen McNally Speaks to the Role of Oncology Nurses in the Opioid EpidemicJuly 18th 2022
Gretchen McNally PhD, ANP-BC, AOCN, spotlights the value that naloxone training for oncology nurses and providers could have for patients who are at a high-risk of overdose.
Are Oncology Nurses Underutilized in Positively Affecting the Opioid Epidemic?July 7th 2022
Gretchen McNally PhD, ANP-BC, AOCNP, discusses the potential impact advanced practice providers and nurses could have in the opioid pandemic if the correct educational opportunities were available.
Real-World Data Identify Significant Differences in Tolerability Among Approved PARP Inhibitors in Ovarian CancerJune 14th 2022
A real-world analysis showed that the proportion of women with ovarian cancer who required dose modifications or treatment discontinuations while receiving PARP inhibitors differed significantly between olaparib, niraparib, and rucaparib.
FDA Follow-Up: Utilizing Pembrolizumab for MSI-H/dMMR Advanced Endometrial CarcinomaApril 8th 2022
Courtney Arn, APRN-CNP, a nurse practitioner who supported cohorts D and K of the KEYNOTE-158 study, discusses the recent approval of pembrolizumab for patients with MSI-H/dMMR advanced endometrial carcinoma.
Self-Awareness Is Critical in Treating Prescribing Patients With Cancer and Substance Abuse DisordersDecember 29th 2021
Kathy Burns, MS, APRN-CNS, AGCNS-BC, of the Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, comments on the importance of self-awareness as an oncology nurse when working to overcome one’s implicit bias.
Clinical Nurse Specialist Explains Meaning and Impact of Implicit Bias on PatientsNovember 26th 2021
Kathy Burns, MS, APRN-CNS, AGCNS-BC, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, comments on the importance of being mindful about one’s implicit bias in the treatment of patients with cancer who have substance use disorders.
Expert Says Pandemic Put a ‘Lens’ on Health Disparities for People Outside the Medical FieldNovember 16th 2021
The director at the Center for Cancer Health Equity, The University of Ohio Comprehensive Cancer Center, discusses how the pandemic put a spotlight on issues of equity within the health care system.
Addressing COVID-19 Vaccine Hesitancy In BIPOC Patients with CancerOctober 6th 2021
Answering questions without judgement and showcasing community members who have received the COVID-19 vaccine without negative outcomes can help alleiviate vaccine-related fears and concerns in BIPOC patients with cancer.
Balstilimab Zalifrelimab Combination Yields Promising Results in Recurrent/Metastatic Cervical CancerSeptember 23rd 2021
A phase 2 trial presented at the 2021 ESMO Annual Congress showed that Balstilimab plus Zalifrelimab induced superior response rates, duration of responses, and overall survival in patients with recurrent/metastatic cervical cancer.
COVID-19 Pandemic Emphasizes Disparities in Cancer CareSeptember 17th 2021
“We’ve had periods of time where things were shut down. We do have telemedicine, that was expanded, but telemedicine doesn’t work for everyone. If you don’t have internet access, if you don’t have the ability to understand the technology….”